baber/WOPTO huggingface dataset:
Patent NZ-333299-A (NZ)
Title: process for recovering processing liquids from a feed mixture
Inventor: ABRY G RAYMOND
IPC: B01D53/14
Filed: 1997-05-14
Abstract: The continuous process for recovering a processing liquid from a feed mixture comprises: a) introducing the feed mixture into a first heating zone and initially heating the feed mixture to a temperature sufficient to volatilize at least some of the more volatile components and at least a portion of the processing liquid while maintaining the  temperature below the decomposition temperature of the processing liquid to produce a vapor stream containing the more volatile component and the vaporized portion of the processing liquid and a residuum; b) the vapor stream is then separated from the residuum in a first separation zone to produce a separated residuum; c) a portion of the separated residuum is passed through a second heating zone at a temperature below the decomposition temperature of the processing liquid to produce a first heated recycle stream; d) the heated recycle stream being admixed with the feed mixture to effect the initial heating of the feed mixture; e) a second portion of the separated residuum is passed through a solids/liquids separation zone to remove any solids present in the second portion of the separated residuum and produce a substantially solids free second recycle stream which is recycled to the first separation zone; f) recovering the processing liquid present in the vapor stream for further use. The feed mixture contains the processing liquid and at least one component that are more volatile than the processing liquid and at least one component that is less volatile than the processing liquid. The residuum of step a) contains the processing liquid, a reduced concentration of the more volatile components and the less volatile components.
Patent NZ-335770-A (NZ)
Title: Prevention and treatment of skeletal disorder with EP2 receptor subtype selective prostaglandin E2 agonists such as tetrazolyl or carboxylic acid derivatives
Inventor: CAMERON KIMBERLY O'KEEFE
IPC: A61K31/381
Filed: 1997-11-27
Abstract: Disclosed is the use of a selective EP2 receptor agonist in the manufacture of a medicament for preventing bone loss and augmenting bone mass in a mammal. The medicament is also for enhancing bone healing facial reconstruction, maxillary reconstruction or mandibular reconstruction, enhancing long bone extension, enhancing the healing rate of a bone graft, enhancing prosthetic ingrowth and inducing vertebral synotosis in a mammal. Particular EP2 agonists disclosed are those of formula I, for which the substituents are defined herein.
Patent NZ-335995-A (NZ)
Title: Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesity
Inventor: DIMARCHI RICHARD D
IPC: C07K14/605
Filed: 1997-11-04
Abstract: This invention relates the use of glucagon-like peptides such as GLP-1, a GLP-1 analog, or a GLP-1 derivative in methods and compositions for reducing body weight.
Patent NZ-337421-A (NZ)
Title: Endotracheal tube
Inventor: PARKER JEFFREY D
IPC: A61M16/04
Filed: 1998-03-17
Abstract: An endotracheal tube (10) having an incomplete posterior bevel (50) extending toward, but not completely through, the anterior wall (36) and a curved lip (54) projecting inward from the anterior wall (36).
Patent NZ-502338-A (NZ)
Title: Method for preparing alkyloxy furanone derivatives, compounds obtained by the method, and intermediates therefor
Inventor: BOUCHET RAPHAEL
IPC: C07K5/117
Filed: 1998-07-09
Abstract: In the compounds of the formula (IVa), (IVb), (IVc) or (IVd), R1 is C1-4alkyl or phenyl-C7-11alkyl. These compounds may be prepared by; a) reacting an arylamine of the formula R3R4CHNH2 (wherein R3 is H or C1-4alkyl and R4 is optionally substituted aryl) with a racemic alkoxyfuranone of the formula (II) (wherein R1 is as defined above) to produce the trans isomer (4R,5R) and (4S,5S) of the formulae (IIIa) and (IIIb) and separating the isomers by crystallization and optionally carrying out salification reactions, or when R3 is hydrogen, the isomers are resolved with an optically active acid; b) optionally subjecting a compound of formulae (IIIa) or (IIIb) in the presence of an acid to epimerization to obtain the cis isomers (4R,5S) or (4S,5R) of the formulae (IIIc) or (IIId); c) subjecting the trans isomer (4R,5R) or (4S,5S) of formulae (IIIa) or (IIIb) to hydrolysis to obtain the trans isomer (4R,5R) or (4S,5S) of compounds of formulae (IVa) or (IVb), which is then salified and/or protected; or subjecting the cis isomer of (4R,5S) or (4S,5R) of formulae (IIIc) or (IIId) to hydrolysis to obtain the cis isomer (4R,5S) or (4S,5R) of formulae (IVc) or (IVd) compounds, which is then salified and/or protected. The compounds of formula (IVa), (IVb), (IVc) or (IVd) may be used as inhibitors of interleukin-1beta converting enzyme.
Patent NZ-502732-A (NZ)
Title: Method of transferring a sheet through a working apparatus by succeeding sheet pushing preceding sheet, typically for veneer press
Inventor: HONDA NORIYUKI
IPC: B65H5/00
Filed: 2000-02-07
Abstract: A first sheet 11 is moved by feed rolls 5,7 partially into a working area of the working apparatus, which is followed by moving a second sheet 11a by the same feed rolls to allow the leading end of the second sheet to be brought into abutment with the trailing end of its preceding first sheet and then to push the first sheet to a predetermined position within the working area. After the first sheet is thus placed and the second sheet is moved back out of the working area, the apparatus is operated to work the first sheet, for example, by pressing. The second sheet is moved forward into abutment with the trailing end of the worked first sheet and moved further while pushing the first sheet towards delivery rolls of the apparatus, which then removes the first sheet out of the working area of the transfer apparatus. Such steps of operation are repeated to transfer a series of sheets successively through the working apparatus.
Patent NZ-504932-A (NZ)
Title: Preparation of octreotide and Tyr3-octreotide from Thr(ol)(tBu)-2-chlorotrityl resin
Inventor: WU HUI-LAN
IPC: C07K7/06
Filed: 2000-06-02
Abstract: Octreotide of formula (IA) or (IB) may be prepared by the following steps: 1) coupling selected amino acids with a Thr(ol)(tBu)-2-chlorotrityl resin to give a straight chain peptide resin compound of formula (IIA) or (IIB); 2) cleaving the straight chain peptide from the resin with a TFA, EDT and H2O solution; and 3) oxidizing the straight chain peptide to obtain the disulfide-containing peptide.
Patent NZ-515049-A (NZ)
Title: Method for reducing a susceptibility to tumor formation induced by 3-deoxyglucosone and precursors thereof
Inventor: BROWN TRUMAN R
IPC: C07K16/18
Filed: 2000-04-17
Abstract: Disclosed herein are methods of using various compounds, which are known to bind to 3-deoxyglucosone (3DG) or precursors thereof, in order to reduce a susceptibility to tumor formation and/or to prevent or delay onset of tumor formation induced by 3DG and its precursors. Also disclosed is the reduction of 3DG levels in high fructose corn syrup so that the high fructose corn syrup is less likely to induce tumor formation.
Patent NZ-518523-A (NZ)
Title: Server use method, server use reservation management apparatus, and program storage medium
Inventor: NISHIMURA TAKANORI
IPC: G06F21/10
Filed: 2001-08-29
Abstract: A method of using a processing server whereby in order for a user terminal apparatus to access a server that performs predetermined processing via a network and uses functions of the processing server, the user terminal apparatus makes a reservation for the use of the processing server via a network to a reservation control apparatus that controls the situation of the reservation of the processing server and uses functions of the processing server based on the reservation comprises: a reservation requesting step of sending reservation request information including a desired service time to use the processing server from the user terminal apparatus to the reservation control apparatus via the network; a reservation accepting step of creating, when the reservation for use of the processing server during the desired service time included in the reservation request information is accepted, authentication information which is used only for the accepted reservation and sending the reservation setting information including this authentication information from the reservation control apparatus to the user terminal apparatus via the network; a storing step of writing and storing the authentication information included in the reservation setting information sent from the reservation control apparatus in a predetermined storage area of the user terminal apparatus; a service requesting step of reading and sending, when the user terminal apparatus accesses and uses the processing server based on the reservation, the authentication information stored in the predetermined storage area from the user terminal apparatus and an authenticating step of deciding whether the use of the processing server by the user terminal apparatus should be accepted or not based on the authentication information sent from the user terminal apparatus.
Patent NZ-520392-A (NZ)
Title: Antibodies that bind human interleukin-18 and methods of making and using
Inventor: GHAYUR TARIQ
IPC: A61P31/04
Filed: 2001-02-09
Abstract: An isolated human monoclonal antibody capable of binding to human IL-18 is described. The antibody can be used in the manufacture of a medicament for inhibiting human IL-18 activity, and for detecting human IL-18 activity in a sample.
Patent NZ-522405-A (NZ)
Title: Electrical stimulation apparatus and method using interchangeable electrode module
Inventor: MO JOSEPH Y
Filed: 2000-04-17
Abstract: Disclosed is an electrical stimulation apparatus, and method for providing electrical stimulation to tissue. The electrical stimulation apparatus includes a base unit (12), and an electrode module (24). The base unit (12) is configured to be hand portable containing a first electrical circuit, and a first battery for supplying electrical energy to the first electrical circuit. A second electrical circuit, and a second battery provide a time/date function. The base unit (12) supports an LCD to provide a visual indication of the various functions of the electrical stimulation apparatus. The electrode module is programmable to enable the prescribing physician to set the treatment protocol for the electrical stimulation apparatus.
Patent NZ-532685-A (NZ)
Title: Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their use in treatign metabolic disorders such as diabetes or impaired glucose tolerance
Inventor: PAN CLARK
IPC: A61K48/00
Filed: 2002-10-04
Abstract: Polypeptides that act as both an agonist of the GLP-1 receptor and an antagonist of the glucagon receptor comprises the amino acid sequence shown in SEQ ID NOs: 6 to 32. Also described are polynucleotides, vectors, host cells, methods of producing the polypeptides and antibodies. The peptides can be used in pharmaceutical compositions for treating metabolic disorders, such as type 2 diabetes and impaired glucose tolerance.
Patent NZ-533946-A (NZ)
Title: Battery-powered walk-behind greensmower
Inventor: DETTMANN BENJAMIN D
IPC: A01D34/58
Filed: 2003-09-24
Abstract: Disclosed is a greensmower having a cutting reel and a traction member and an independent electric circuit and motor for driving each. A handle is attached to the reel for mower guidance by an operator in a walk-behind position. Separate electric controls are connected to each motor for separate speeds for each motor and thereby control the clip rate of the mowing. There are low battery power read-outs and automatic shutoffs. Provision is made for traction powering of the mower even when the reel motor is not operating because of low battery power. A lift-out battery pack is shiftably mounted on the mower for producing the desired force of the mower on the ground.
Patent NZ-534020-A (NZ)
Title: Reciprocating fluid engine
Inventor: BILYK DEREK
IPC: F02B75/34
Filed: 2002-12-31
Abstract: A reciprocating fluid engine is provided having a high frequency and a high stroke force. The reciprocating fluid engine may be used to power a vehicle, such as a toy ornithopter. The reciprocating fluid engine has a piston in which every stroke is a drive stroke. An ornithopter having the reciprocating fluid engine has a piston in which each piston stroke moves the wings of the ornithopter either up or down, thereby causing the wings to flap.
Patent NZ-535335-A (NZ)
Title: Method and apparatus for robust local mobility management in a mobile network
Inventor: VENKITARAMAN NARAYANAN
IPC: H04L69/40
Filed: 2003-02-14
Abstract: A method and apparatus for robust mobility management in a network having a mobile node, a mobility anchor point, a correspondent node, a home agent and an access router and operating under a hierarchical protocol. The mobile node sends the address of the mobility anchor point to the correspondent node and sends the address of the mobile node on the network of the access router to the home agent and to the mobility anchor point. When failure of the mobility anchor point occurs, the mobile node recovers from the failure by selecting a new mobility anchor point or operating under a non-hierarchical protocol. Failure is detected by an intermediate router or by a correspondent node when messages fail to reach the mobility anchor point.
Patent NZ-535346-A (NZ)
Title: Framing tool with automatic fastener-size adjustment
Inventor: LAUBACH MARCO
IPC: B25C7/00
Filed: 2003-05-21
Abstract: Shear block 40 is secured to nosepiece 22 and has boss 52. Nosepiece 22 has a workpiece contacting element 56 slidingly attached and having at least one cap having at least one cap 54 configured to engage boss 52 when element 56 engages the workpiece 16. (62) Divided out of 534181
Patent NZ-535509-A (NZ)
Title: Energy management system and method
Inventor: TURNER JAMES H
IPC: G06Q10/00
Filed: 2003-03-28
Abstract: A method and system that enable a utility to monitor and manage demand for a commodity, such as electricity, natural gas or water, is disclosed. The commodity is supplied to customer sites and at each site a number of devices use the commodity. The instantaneous rate at which the commodity is delivered to a subset of the customer devices is measured and sent to the utility. A program may be activated to manage the usage of the commodity by the subset of the customer devices if the utility needs to manage capacity.
Patent NZ-537147-A (NZ)
Title: Method and apparatus for particle analysis
Inventor: SOWERBY STEPHEN JOHN
Filed: 2004-12-13
Abstract: A method is provided for detecting, measuring, or controlling particles and/or electromagnetic radiation, comprising providing a deformable material containing a deformable aperture defining a path for particles or radiation, adjusting the deformable aperture to a prescribed geometry and/or size by deforming the deformable material to change at least one of the parameters of the path defined by the deformable aperture, and causing the particle or radiation to be detected, measured, or controlled to enter the deformable aperture. The method includes the step of monitoring the geometry and/or size of the deformable aperture and controlling the adjustment of the size of the deformable aperture in response to such monitoring. The required apparatus is easily fabricated from inexpensive materials. Furthermore the deformable aperture can be tuned to the appropriate geometry post fabrication, and the ability to adjust the aperture geometry renders it capable of discriminating a plurality of differently sized particles.
Patent NZ-540657-A (NZ)
Title: High-yielding, GMP-compatible, commercially feasible process for producing highly purified alphavirus replicon particle (ARP) preparations for use in human and veterinary medicine
Inventor: SMITH JONATHAN F
IPC: C12N15/86
Filed: 2003-12-12
Abstract: Described are methods for producing alphavirus replicon particles in high yield. Replicon RNAs are electro orated into permissive cells, where the cells are at a relatively high density, together with at least one helper nucleic acid providing the necessary functions for packaging. After a growth period in an appropriate medium, alphavirus replicon particles are harvested from the surfaces of the cells in which they were produced using a salt wash in which the salt concentration is from about 0.2 to about 5M sodium chloride, calcium chloride, magnesium chloride, potassium chloride, ammonium acetate, ammonium bicarbonate, among others. After dilution, if necessary, the particles can be purified by a suitable chromatographic technique.
Patent NZ-541517-A (NZ)
Title: Switch sensing to prevent inadvertent motor startup
Inventor: BROTTO DANIELE C
IPC: H02H11/00
Filed: 2004-02-02
Abstract: Methods and apparatus for preventing sudden inadvertent operation of a motor of a tool or appliance when the motor 18 is initially electrically connected to a power source with the motor control switch in the 'on' position are disclosed. If the motor switch 22 is 'on' when power is connected then an electrical switch 42 is used in disabling the operation of the motor until the motor switch is cycled through the 'off' position.
Patent NZ-542580-A (NZ)
Title: Wall construction of architectural structure
Inventor: MATSUFUJI YASUNORI
IPC: E04B2/02
Filed: 2003-09-04
Abstract: Wall construction of an architectural structure, where outer walls with earthquake- and wind-resistance and inner walls with relatively inferior earthquake resistance etc. are adequately combined so that design loads are appropriately received by each portion of the construction. Wall construction of an architectural structure includes brickwork outer walls (2) constructed from bricks (A-D) and metal plates (51) piled up. Fasteners (60, 62, 63, 70) penetrating through bolt insertion holes (7) of the bricks are fastened, and upper and lower bricks are integrally connected to each other under prestress by the fasteners. Inner walls (3) are constructed inside the outer walls, and shear reinforcement members (10, 20) connect the inner walls and the outer walls to each other. The inner walls are constructed as wall bodies by a dry construction method, the wall bodies being capable of supporting a long-term vertical load such as a roof load. A short-term horizontal load such as earthquake force acting on the inner walls is transmitted to the outer walls by the shear reinforcement members.
Patent NZ-545202-A (NZ)
Title: Abuse-proofed dosage form comprising opiods and a high molecular weight polyethylene oxide
Inventor: BARTHOLOMAUS JOHANNES
IPC: B29C48/40
Filed: 2004-08-05
Abstract: Disclosed is an abuse-proofed dosage form thermoformed by extrusion without discolouration, which contains, in addition to one or more active ingredients with abuse potential selected from opioids (A) optionally together with physiologically acceptable auxiliary substances (B), at least one synthetic or natural polymer (C) selected from the group comprising polyalkylene oxides (such as a polyethylene glycol), copolymers and the mixtures there of having a molecular weight of at least 0.5 million g/mol, and optionally at least one wax (D), wherein component (C) and the optionally present component (D) is/are present in quantities such that the dosage form has a breaking strength of at least 500 N.
Patent NZ-546070-A (NZ)
Title: Mitoquinone derivatives used as mitochondrially targeted antioxidants
Inventor: TAYLOR KENNETH MARTIN
IPC: C07F9/54
Filed: 2004-08-23
Abstract: Disclosed is a compound comprising a lipophilic cationic moiety selected from the group consisting of triphenylphosphonium, tribenzylammonium and phosphonium, linked by a linking moiety which comprises (C)n wherein n is an integer from 2 to 20 to an antioxidant moiety selected fro the group consisting of a quinine or a quinol, vitamin E or a vitamin E derivative, a fullerene, butylated hydroxyanisole, butylated hydroxytoluene, 5,5dimethylpyrroline-N-oxide, tert-butylnitrosobenzene, tert-nitrosobenzene and alpha-phenyl-tert-butylnitrone and an anionic complement is not (i) an alkyl sulfonate, (ii) an aryl sulfonate, (iii) hexafluroantimonate, hexafluoroarsenate or hexafluorophosphate, (iv) trifluoromethanesulfonate, tetraphenylborate, tetra(perfluorophenyl)borate or another tetrafluoroborate or (v) a halide, wherein the cationic species is capable of mitochondrially targeting the antioxidant species, and the salt form is chemically stable and/or the anionic complement does not exhibit reactivity against the antioxidant moiety, the cationic moiety or the linking moiety.
Patent NZ-546575-A (NZ)
Title: Plate-shaped cementitious product and production method
Inventor: FAMY CHARLOTTE
IPC: E04C2/26
Filed: 2004-09-15
Abstract: A fiber-reinforced cementitious board product is prepared from a sheet material aqueous suspension that does not contain siliceous sand by superposition of thicknesses of the material on a filtration screen until the desired board thickness is obtained, the board then being autoclaved. The material of the matrix includes a hydraulic binder such as Portland cement, fibrous plant material such as wood fibre, and at least one pozzolan chosen from aluminosilicates, calcium aluminosilicates, amorphous silica, and material containing essentially amorphous silica that is capable of undergoing a pozzolanic reaction. In any case each of the materials has a particle size with mean diameter greater than 1 micrometer.
Patent NZ-547376-A (NZ)
Title: Transdermal pharmaceutical spray formulations comprising a VP/VA copolymer and a non-aqueous vehicle
Inventor: LULLA AMAR
IPC: A61K9/70
Filed: 2004-10-21
Abstract: Provided is a transdermal spray formulation comprising: a) a pharmaceutically active agent; b) 0.1% to 5.0% by weight VPNA copolymer; c) at least 60% by weight of ethanol; and d) optionally a penetration enhancer, which, if present, is present in an amount of 0.01% to 5.0% by weight of the composition. Further provided is the use of the composition in the manufacture of a medicament formulated to form a pharmaceutically active film upon spraying onto the skin of a subject.
Patent NZ-548627-A (NZ)
Title: Improved latching means for a combination step and extension ladder
Inventor: DELAFORCE RONALD THOMAS
Filed: 2006-07-18
Abstract: A latching device for a dual purpose ladder which can be used as a step ladder or an extension ladder. The latching device comprises at least one latch member mounted on a rotatable shaft which extends between the stiles of one of the ladder sections and being biased towards a latch engaging position, a latch engaging bar or rail secured to the other ladder section, and a manual actuator operatively associated with the latch member for effecting pivotal movement of the latch member so as to disengage same from the latch engaging bar or rail to enable the two ladder sections to pivot relative to one another, the latch member being arranged so that it will automatically engage with the latch engaging bar or rail when the other ladder section is rotated to an extended position.
Patent NZ-550412-A (NZ)
Title: Method and composition for treating rhinitis
Inventor: PERESWETOFF-MORATH LENA
IPC: A61K9/00
Filed: 2005-05-06
Abstract: The disclosure relates to a homogeneous pharmaceutical composition for the treatment of rhinitis by nasal or ocular administration comprising zwitterionic cetirizine, a polar lipid liposome and a pharmaceutically-acceptable aqueous carrier. Also disclosed is a process for the preparation of said composition and the use of said composition for the manufacture of a medicament for the treatment of rhinitis.